Intraparenchymal hematoma with significant mass effect treated with bypass activity of factor eight inhibitors
The authors present the case of an 80-year-old woman with myelodysplastic syndrome treated with chemotherapy and apixaban, a direct oral anticoagulant, victim of an intracranial hemorrhage. She presented to the emergency room with an altered mental state and was found to have a large intraparenchymal hematoma with significant mass effect. Our patient received FEIBA (Factor …